NFS1 expression was assessed with a reverse transcription-polymerase chain reaction and western blot analysis in four human GC cell lines (HGC-27, AGS, MKN-1, and BGC-823) and one normal gastric epithelial cell line (GES-1) to determine the phenotypic consequence of NFS1 in GC. Here, NFS1 is linked to gastric cancer.